Regeneron Pharmaceuticals Inc (REGN) reported a profit for its third quarter that Increased from the same period last year and beat the Street estimates.
The company's bottom line came in at $1.460 billion, or $13.62 per share. This compares with $1.341 billion, or $11.54 per share, last year.
Excluding items, Regeneron Pharmaceuticals Inc reported adjusted earnings of $1.287 billion or $11.83 per share for the period.
Analysts on average had expected the company to earn $9.64 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 0.9% to $3.754 billion from $3.721 billion last year.
Regeneron Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings: $1.460 Bln. vs. $1.341 Bln. last year.-EPS: $13.62 vs. $11.54 last year.-Revenue: $3.754 Bln vs. $3.721 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.